These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
344 related articles for article (PubMed ID: 15596040)
1. Mechanism and biological significance of CD44 cleavage. Nagano O; Saya H Cancer Sci; 2004 Dec; 95(12):930-5. PubMed ID: 15596040 [TBL] [Abstract][Full Text] [Related]
2. Presenilin-dependent gamma-secretase activity mediates the intramembranous cleavage of CD44. Murakami D; Okamoto I; Nagano O; Kawano Y; Tomita T; Iwatsubo T; De Strooper B; Yumoto E; Saya H Oncogene; 2003 Mar; 22(10):1511-6. PubMed ID: 12629514 [TBL] [Abstract][Full Text] [Related]
3. Cell-matrix interaction via CD44 is independently regulated by different metalloproteinases activated in response to extracellular Ca(2+) influx and PKC activation. Nagano O; Murakami D; Hartmann D; De Strooper B; Saftig P; Iwatsubo T; Nakajima M; Shinohara M; Saya H J Cell Biol; 2004 Jun; 165(6):893-902. PubMed ID: 15197174 [TBL] [Abstract][Full Text] [Related]
4. Proteolytic release of CD44 intracellular domain and its role in the CD44 signaling pathway. Okamoto I; Kawano Y; Murakami D; Sasayama T; Araki N; Miki T; Wong AJ; Saya H J Cell Biol; 2001 Nov; 155(5):755-62. PubMed ID: 11714729 [TBL] [Abstract][Full Text] [Related]
5. Tumor cells enhance their own CD44 cleavage and motility by generating hyaluronan fragments. Sugahara KN; Hirata T; Hayasaka H; Stern R; Murai T; Miyasaka M J Biol Chem; 2006 Mar; 281(9):5861-8. PubMed ID: 16407205 [TBL] [Abstract][Full Text] [Related]
6. MiR-199a-5p represses the stemness of cutaneous squamous cell carcinoma stem cells by targeting Sirt1 and CD44ICD cleavage signaling. Lu RH; Xiao ZQ; Zhou JD; Yin CQ; Chen ZZ; Tang FJ; Wang SH Cell Cycle; 2020 Jan; 19(1):1-14. PubMed ID: 31809227 [TBL] [Abstract][Full Text] [Related]
8. CD44 and its partners in metastasis. Jothy S Clin Exp Metastasis; 2003; 20(3):195-201. PubMed ID: 12741678 [TBL] [Abstract][Full Text] [Related]
9. Enhanced membrane-type 1 matrix metalloproteinase expression by hyaluronan oligosaccharides in breast cancer cells facilitates CD44 cleavage and tumor cell migration. Kung CI; Chen CY; Yang CC; Lin CY; Chen TH; Wang HS Oncol Rep; 2012 Nov; 28(5):1808-14. PubMed ID: 22922740 [TBL] [Abstract][Full Text] [Related]
10. Hyaluronan-CD44 interaction promotes microRNA signaling and RhoGTPase activation leading to tumor progression. Bourguignon LY Small GTPases; 2012; 3(1):53-9. PubMed ID: 22714418 [TBL] [Abstract][Full Text] [Related]
11. Cell aggregation activates small GTPase Rac1 and induces CD44 cleavage by maintaining lipid raft integrity. Li D; Park Y; Hemati H; Liu X J Biol Chem; 2023 Dec; 299(12):105377. PubMed ID: 37866630 [TBL] [Abstract][Full Text] [Related]
12. Hyaluronan-CD44 interaction promotes oncogenic signaling, microRNA functions, chemoresistance, and radiation resistance in cancer stem cells leading to tumor progression. Bourguignon LY; Shiina M; Li JJ Adv Cancer Res; 2014; 123():255-75. PubMed ID: 25081533 [TBL] [Abstract][Full Text] [Related]
13. Activation of Matrix Hyaluronan-Mediated CD44 Signaling, Epigenetic Regulation and Chemoresistance in Head and Neck Cancer Stem Cells. Bourguignon LYW; Earle C; Shiina M Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28837080 [TBL] [Abstract][Full Text] [Related]
15. Castanospermine suppresses CD44 ectodomain cleavage as revealed by transmembrane bioluminescent sensors. Noda N; Ozawa T J Cell Sci; 2022 Mar; 135(6):. PubMed ID: 35194645 [TBL] [Abstract][Full Text] [Related]
16. Hyaluronan-mediated CD44 activation of RhoGTPase signaling and cytoskeleton function promotes tumor progression. Bourguignon LY Semin Cancer Biol; 2008 Aug; 18(4):251-9. PubMed ID: 18450475 [TBL] [Abstract][Full Text] [Related]
17. CD44 interaction with Na+-H+ exchanger (NHE1) creates acidic microenvironments leading to hyaluronidase-2 and cathepsin B activation and breast tumor cell invasion. Bourguignon LY; Singleton PA; Diedrich F; Stern R; Gilad E J Biol Chem; 2004 Jun; 279(26):26991-7007. PubMed ID: 15090545 [TBL] [Abstract][Full Text] [Related]
18. Characterization of CD44 intracellular domain interaction with RUNX2 in PC3 human prostate cancer cells. Senbanjo LT; AlJohani H; Majumdar S; Chellaiah MA Cell Commun Signal; 2019 Jul; 17(1):80. PubMed ID: 31331331 [TBL] [Abstract][Full Text] [Related]
19. CD44 enhances invasion of basal-like breast cancer cells by upregulating serine protease and collagen-degrading enzymatic expression and activity. Montgomery N; Hill A; McFarlane S; Neisen J; O'Grady A; Conlon S; Jirstrom K; Kay EW; Waugh DJ Breast Cancer Res; 2012 May; 14(3):R84. PubMed ID: 22621373 [TBL] [Abstract][Full Text] [Related]
20. Presenilin-dependent intramembrane proteolysis of CD44 leads to the liberation of its intracellular domain and the secretion of an Abeta-like peptide. Lammich S; Okochi M; Takeda M; Kaether C; Capell A; Zimmer AK; Edbauer D; Walter J; Steiner H; Haass C J Biol Chem; 2002 Nov; 277(47):44754-9. PubMed ID: 12223485 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]